Edition:
United Kingdom

Bioanalytical Systems Inc (BASI.OQ)

BASI.OQ on NASDAQ Stock Exchange Capital Market

2.82USD
15 Dec 2017
Change (% chg)

$0.03 (+1.08%)
Prev Close
$2.79
Open
$2.80
Day's High
$2.85
Day's Low
$2.80
Volume
13,853
Avg. Vol
9,476
52-wk High
$2.95
52-wk Low
$0.65

Latest Key Developments (Source: Significant Developments)

Bioanalytical Systems entered third forbearance agreement,fourth amendment to credit agreement-SEC filing
Monday, 3 Oct 2016 

Bioanalytical Systems Inc : Effective Sept 30, Co entered third forbearance agreement ,fourth amendment to credit agreement-SEC filing . Third forbearance agreement amends maturity dates for term and revolving loans under credit agreement to october 31, 2016 . Third forbearance agreement removes additional financial covenant contained in second forbearance agreement .In connection with third forbearance agreement, CO agreed to reimburse Huntington Bank for certain legal fees ,to pay a loan forbearance fee..  Full Article

Basi Q3 loss per share $0.05
Thursday, 11 Aug 2016 

Bioanalytical Systems Inc : Basi reports third quarter results .Q3 revenue fell 17.8 percent to $5.053 million.  Full Article

Bioanalytical Systems elects Larry Boulet as Board's chairman
Thursday, 4 Aug 2016 

Bioanalytical Systems Inc :On July 28, company’s board of directors voted unanimously to elect Larry Boulet as chairman of the board - SEC Filing.  Full Article

Bioanalytical Systems says John B. Landis retired as Chairperson
Friday, 22 Jul 2016 

Bioanalytical Systems Inc : Says John B. Landis retired as Chairperson of the board - SEC Filing Source - http://bit.ly/29U2Ks4 Further company coverage: [BASI.O] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Bioanalytical Systems posts Q2 loss per share of $0.03
Thursday, 12 May 2016 

Bioanalytical Systems Inc : BASI reports second quarter results . Says for three months ended March 31, 2016, revenue was $5.3 million, a 6.8 pct decrease . Exploring initiatives to address solutions to credit issues, which include evaluation, pursuit of various sources of financing .Q2 loss per share $0.03.  Full Article

Bioanalytical Systems appoints Jill C. Blumhoff as CFO
Wednesday, 11 May 2016 

Bioanalytical Systems Inc : Bioanalytical Systems Inc announces appointment of new chief financial officer . Says Jill C. Blumhoff appointed CFO .Blumhoff succeeds Jeffrey Potrzebowski effective with his retirement from company on May 9, 2016.  Full Article

BRIEF-Bioanalytical Systems reports Q3 earnings per share of $0.03

* Qtrly ‍revenue amounted to $5.8 million, up 15 percent Source text: (http://bit.ly/2uH6Zlw) Further company coverage: